top of page
Unlock the Latest Industry Insights
Subscribe to our newsletter to remain informed.
We will provide you with crucial industry information and ensure that you are up-to-date on the most recent events that you would not want to overlook.
Nitrosamine Contamination in Pharmaceuticals
Nitrosamine impurities in pharmaceutical products have become a major concern in recent years due to their genotoxic and carcinogenic...
BioBoston Consulting
Mar 27, 20232 min read
GXP Training: Ensuring Compliance and Quality in the Pharmaceutical and Biotech Industries
GXP training is an essential aspect of the pharmaceutical and biotech industries. It refers to a set of guidelines that regulate the...
BioBoston Consulting
Mar 25, 20234 min read
Consulting Firms Pharmaceutical Industry: Driving Growth and Innovation Amid Complexity
The pharmaceutical industry is one of the most dynamic and rapidly evolving sectors in the world. With the rise of new diseases,...
BioBoston Consulting
Mar 25, 20234 min read
Breaking Through Phase 2: Overcoming the Challenges of Transitioning to Phase 3 in Drug Development
The transition from phase 2 to phase 3 of drug development is a critical step in the drug development process. Phase 2 is focused on...
BioBoston Consulting
Mar 22, 20233 min read
Compliance Made Easy
How BioBoston Consulting Can Help Navigate the Complex World of Pharmaceutical Regulations Regulatory compliance is a critical aspect of...
BioBoston Consulting
Mar 22, 20233 min read
Mastering Part 211 Subpart E: Control of Components & Containers
In drug manufacturing, the quality of components and containers and closures used to store drug products is crucial. The FDA has...
BioBoston Consulting
Mar 17, 20234 min read
Part 211 Subpart D Equipment Requirements
Subpart D of Part 211 of the Code of Federal Regulations (CFR) deals with equipment used in the manufacture, processing, packaging, and...
BioBoston Consulting
Mar 17, 20234 min read
A Guide to PART 211 Subpart C Regulations
PART 211 Subpart C of the Code of Federal Regulations (CFR) outlines the requirements for buildings and facilities used in the...
BioBoston Consulting
Mar 14, 20234 min read
How to master PART 211 Subpart B: Organizing Personnel for Quality Pharma Manufacturing
PART 211 of the Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals provides guidelines for the...
BioBoston Consulting
Mar 14, 20234 min read
Unlocking FDA Approval: A Step-by-Step Guide for Successfully Marketing Your New Drug
Developing a new drug is a long and expensive process. Once a drug has been developed, the next step is to obtain approval from the U.S....
BioBoston Consulting
Mar 14, 20233 min read
Maximizing Compliance and Minimizing Costs: The Benefits of Outsourcing Regulatory Training
For biotech and pharmaceutical startups, regulatory compliance is critical for success. In addition to developing innovative products,...
BioBoston Consulting
Mar 14, 20232 min read
bottom of page